INTRODUCTION
============

Nutritionists have focused on increasing consumption of important polyunsaturated fatty acid (PUFA), particularly conjugated linoleic acid (CLA) that could have benefits to body composition, the immune system and atherosclerosis ([@b9-ajas-25-5-648-8]). The major CLA, *cis*-9, *trans-11* isomer, in nature originates from ruminal biohydrogenation of dietary linoleic acid (C18:2) and linolenic acid (C18:3), as well as from endogenous synthesis from *trans-11* vaccenic acid (TVA) by Δ^9^-desaturase ([@b22-ajas-25-5-648-8]). A positive linear relationship, in adipose tissue, between *cis*-9, *trans*-*11* CLA and TVA levels has been reported in some studies ([@b10-ajas-25-5-648-8]; [@b2-ajas-25-5-648-8]). Over 85% of *cis*-9, *trans*-*11* CLA in milk resulted from desaturation of TVA via the stearoyl-CoA desaturase (SCD) enzyme ([@b14-ajas-25-5-648-8]). Thus, increasing SCD gene expression may improve the functional food attributes of lamb by increasing the *cis*-9, *trans-11*CLA content of the tissue.

In our previous study, it was found that addition of tea saponins (TS) and soybean oil (SO) could reduce methane emission through affecting the rumen bacteria ([@b11-ajas-25-5-648-8]). Formation of CLA in the rumen has been mainly associated with bacterial activity ([@b6-ajas-25-5-648-8]). [@b17-ajas-25-5-648-8] suggested that protozoa in the rumen may increase the supply of CLA and other unsaturated fatty acids. Additionally, TS could reduce the population of protozoa ([@b11-ajas-25-5-648-8]). Therefore, TS may affect fatty acid composition of ruminant meat. In contrast, CLA contents in goat milk, subcutaneous adipose tissue of heifers and lambs have been shown to increase by dietary inclusion of C18:2 rich-oil seeds expression ([@b12-ajas-25-5-648-8]; [@b3-ajas-25-5-648-8]; [@b8-ajas-25-5-648-8]). Thus the objectives of this study were to evaluate the effects of TS and SO added to the diets of growing lambs on intramuscular fatty acid profile and to analyze the relationship between *cis*-9, *trans*-*11* CLA synthesis and SCD gene expression.

MATERIALS AND METHORDS
======================

Sampling procedures
-------------------

Samples of *longissimus dorsi* (LD) muscle were taken from the growing lambs in the experiment of [@b11-ajas-25-5-648-8]. In their study, thirty-two Huzhou growing lambs were assigned to four dietary treatments with TS and SO as main effects, to investigate the effects of TS and SO on methane production, fermentation and microbial population in the rumen of growing lambs. The diets included: NTNS (no TS or SO), TS (3 g/d), SO (30 g/kg of the DM), and TS plus SO (TS-SO). After the growth trial, half of the lambs (body weight = 19.6 (SE = 0.58)) from each treatment were slaughtered. The LD muscle samples were collected at between 10 and 12 ribs immediately after the animals were slaughtered. A sub-sample of LD muscle (about 10 g) was stored frozen at −20°C for fatty acid analysis. Another sub-sample of LD muscle (5 g) was immediately frozen in liquid nitrogen and stored at −80°C for subsequent RNA extraction to determine the SCD gene expression.

Parameters measurements
-----------------------

Total lipids from sub-samples of LD muscle were extracted with chloroform: methanol (2:1, v/v). The lipid extracts were methylated according to the method of [@b18-ajas-25-5-648-8]. Fatty acids methyl ester (FAME) were separated by gas chromatograph (Agilent GC6890N) equipped with a flame ionization detector using a fused silica capillary column (DB-5MS, 30 m×0.25 mm×0.25 μm). Individual FAME was identified by comparing with standards and quantified from peak areas to result in percentages of total fatty acids. Results for each fatty acid were expressed as percentage of the sum of all identified fatty acids.

Total RNA was extracted from the LD muscle samples according the TRIzol procedure (Invitrogen, Carlsbad, CA, USA), which included an initial centrifugation step to remove lipids from the extract according to the manufacturer's directions. Total RNA was synthesized to cDNA by using random hexamer primers and performed with a PrimeScript™ RT kit (Perfect Real Time; Takara, Dalian, China).

The PCR assays for enumeration of SCD were performed on an ABI 7500 Real-Time PCR System (Applied Biosystems, Foster City, USA) using the SYBR^®^ *Premix Ex Taq*™ (Takara, Dalian, China). Primers for SCD (F: 5′-CGCTGGCACATCAACTTTACC-3′, R: 5′-TTTCCTCTCCAGTTCTTTTCATCC-3′) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, F: 5′-TTGTGATGGGCGTGAACC-3′, R: 5′-CCCTCCACGATGCCAAA-3′) were designed based on the mRNA sequences of ovine SCD (AY292284) and GAPDH (AF030943), which were published at GenBank. Primers for each gene were designed to flank a region that contains at least one intron to ensure that no contaminating genomic DNA was amplified. They were synthesized by Invitrogen Corp. (Shanghai, China). The mRNA of GAPDH was used as an internal standard for the determination of SCD mRNA levels. Amplification condition was as follows: one cycle at 95°C for 1 min for initial denaturation, followed by 45 cycles of 95°C for 10 s, 54°C for 10 s and 72°C for 34 s. The melting curve analysis of amplication products was performed at the end of each PCR reaction to confirm that single PCR product was detected. Upon 1.2% agarose gel electrophoresis, all PCR products moved with one single band and showed the expected size. Amplification efficiencies for each primer pair were investigated by examining gradient dilution series of total ruminal microbial DNA template on the same plate in triplicate.

Calculation and statistical analysis
------------------------------------

Abundance of SCD mRNA was expressed as a proportion of GAPDH mRNA according to the equation: Relative quantification of SCD = 2^−(Ct\ SCD−Ct\ GAPDH)^, where Ct represents threshold cycle.

Data were analyzed as a completely randomized block experiment using the GLM procedure of SAS ([@b23-ajas-25-5-648-8]). The experimental model was 2-way interactions and the main effect was TS and SO. The fatty acid profiles and SCD gene expression were studied by analysis of variance including the effects of TS, SO and their interaction. Multiple comparisons of means among treatments were carried out by Duncan's multiple range tests. Statistical significance was considered as p≤0.05.

RESULTS AND DISCUSSIONS
=======================

Fatty acid composition of LD muscle
-----------------------------------

The results of intramuscular fat and fatty acid composition of LD muscle affected by TS and SO are presented in [Table 1](#t1-ajas-25-5-648-8){ref-type="table"}. The intramuscular fat level was higher for lambs fed diets with SO (p\<0.05). The productive performance of animals was not significantly different among treatments due to the restricted feeding ([@b11-ajas-25-5-648-8]), suggesting that the additives rather than the growth rate contribute to the difference of fatty acid composition of LD muscle. The proportion of myristic (C14:0) was decreased (p\<0.05) by TS and SO. [@b7-ajas-25-5-648-8] suggested that decrease in proportion of medium-chain fatty acid may be due to decreases in activity and mRNA abundances of lipogenic enzymes such as acetyl CoA and fatty acid synthesis. Soybean oil addition did not have a significant effect on the proportion of palmitic (C16:0) and stearic acid (C18:0) (p\>0.05). However, [@b22-ajas-25-5-648-8] observed that C16:0 and C18:0 decreased with 80 g/kg of soybean oil inclusion in the diet. The difference between the two results may be due to the level of dietary oil and basal diet used.

The decrease in saturated fatty acid (SFA) was also probably due to the fact that the increase in the availability of exogenous fatty acids inhibits the *de novo* synthesis of fatty acids ([@b22-ajas-25-5-648-8]). The proportions of monounsaturated fatty acid (MUFA), C16:1 and C18:1, in the LD muscle was not affected (p\>0.05) by oil addition. This was similar to results in sheep fed a diet containing 60 g/kg DM of sunflower seed oil ([@b5-ajas-25-5-648-8]), but in contrast to the finding that when lambs were fed linseed or linseed plus fish oil increases in C18:1 were observed in muscle ([@b21-ajas-25-5-648-8]). However, a decrease in C18:1 in muscle, adipose and liver was observed in lambs fed 60 g of safflower oil/kg DM ([@b13-ajas-25-5-648-8]). These observations suggested that the impact of dietary oil addition on MUFA was dependent on the type of oil addition.

The TVA was increased when either TS or SO were added to the diets (p\<0.05). The proportion of *cis*-9, *trans*-*11* CLA was increased (p\<0.05) by SO, but decreased by TS (p\<0.05). A negative TS×SO interaction was also observed (p\<0.05). Total CLA was decreased by TS, but increased by SO (p\<0.05). One explanation for the decrease in CLA by TS may be that the TS reduced the population of protozoa ([@b11-ajas-25-5-648-8]). Protozoa contain a greater proportion of unsaturated fatty acids and CLA than the bacteria. The presence of protozoa in the rumen could increase the supply of CLA and other unsaturated fatty acids for lower gut absorption by ruminants ([@b17-ajas-25-5-648-8]). However, [@b25-ajas-25-5-648-8] reported that protozoa-free lambs had higher proportion of *cis*-9, *trans*-11 CLA in their tail muscle. The differences between these results may be due to the tissues sampled. *Trans-11* vaccenic acid and CLA are intermediates formed during ruminal biohydrogenation of dietary linoleic acid ([@b19-ajas-25-5-648-8]). Some researchers reported that unsaturated fatty acid and CLA in muscle of lambs were increased by supplementation of soybean oil or safflower oil ([@b13-ajas-25-5-648-8]; [@b22-ajas-25-5-648-8]; [@b1-ajas-25-5-648-8]), while [@b4-ajas-25-5-648-8] did not observe changes in TVA or *cis*-9, *trans*-*11* CLA when cattle were supplemented with 50 g/kg DM of safflower oil in a finishing diet. [@b10-ajas-25-5-648-8] observed no change in TVA or *cis*-9, *trans*-*11* CLA proportion of LD muscle when extruded full-fat soybeans was supplemented to the diet of cattle at 127 g/kg of diet DM. However, when extruded full-fat soybean was increased to 256 g/kg of diet DM, TVA and *cis*-9, *trans-11* CLA proportion increased in LD muscle. In the current study, 30 g/kg DM of soybean oil addition to the diet of growing lambs increased TVA and *cis*-9, *trans*-*11* CLA by 3 and 7 percentages, respectively.

The TS and SO treatments did not affect the proportion of eicosapentaenoic acid (C20:5) and docosahexaenoic acid (C22:6) in intramuscular fat. These fatty acids are synthesized by the elongation and desaturation of linolenic acid ([@b24-ajas-25-5-648-8]), the proportion of which was not affected by TS or SO in this study. The proportion of docasapentaenoic (C22:5) was increased by SO addition, consistent with the result of [@b22-ajas-25-5-648-8].

Stearoyl-CoA desaturase gene expression
---------------------------------------

Addition of TS was associated with substantial reduction (p\<0.05; [Figure 1](#f1-ajas-25-5-648-8){ref-type="fig"}) in the quantity of SCD mRNA relative to GAPDH. In contrast, the SO-contained diets significantly increased (p\<0.05) the SCD gene expression. A TS×SO interaction was observed (p\<0.05). Stearoyl-CoA desaturase is known as the Δ^9^ desaturase that catalyzes the biosynthesis of MUFA by introducing the first *cis* double bond in the Δ^9^ position (between carbons 9 and 10) ([@b16-ajas-25-5-648-8]). *Trans-11* vaccenic acid is a substrate for SCD, and can be converted to *cis*-9, *trans*-*11* CLA by endogenous SCD. A significant linear relationship existed between TVA and *cis-9*, *trans-11* CLA ([@b27-ajas-25-5-648-8]; [@b26-ajas-25-5-648-8]). [@b20-ajas-25-5-648-8] suggested the variation in milk *cis*-9, *trans*-*11* CLA levels were related to both ruminal biohydrogenation and SCD activity in the mammary gland. [@b19-ajas-25-5-648-8] did not observe the negative effect on the SCD activity or expression in subcutaneous adipose tissues when steers were fed a diet with corn oil. Work in rodents has shown that diets rich in PUFA reduced hepatic abundance of SCD ([@b15-ajas-25-5-648-8]). Results from this study indicate that SCD expression in muscle was increased with SO addition, but decreased by TS. This was also confirmed indirectly from the ratio of *cis*-9, *trans*-*11* CLA to TVA, which was increased by addition of SO, but decreased by TS (p\<0.05; [Table 1](#t1-ajas-25-5-648-8){ref-type="table"}).

CONCLUSIONS
===========

The intramuscular fat of lambs fed a diet containing TS had lower proportion of *cis*-9 *trans*-*11* CLA. Dietary addition of linoleic acid-rich soybean oil was effective in decreasing SFA proportion and increasing the proportion of PUFA and CLA in the LD muscle, which is a desirable change in meat and beneficial for human health. It is inferred that the *cis*-9 *trans*-*11* CLA synthesis may be mediated through the expression of SCD gene.
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![The mRNA abundance of stearoyl-CoA desaturase (SCD) relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in *longissimus dorsi* muscle from growing lambs with different additives: no tea saponins or soybean oil (NTNS), tea saponins (TS, 3 g/kg DM), soybean oil (SO, 30 g/kg DM), and tea saponins plus soybean oil (TS-SO). (A) Multiple comparisons of means among treatments analyzed by Duncan's multiple range tests. ^a,b^ Means with different letter differ significantly (p\<0.05). (B) Results by analysis of variance including the effects of TS, SO and their interaction; *P*~TS~ = 0.019, *P*~SO~ = 0.016, *P*~TS×SO~ = 0.002.](ajas-25-5-648-8f1){#f1-ajas-25-5-648-8}

###### 

Effects of addition of tea saponins and soybean oil on fatty acid composition of the intramuscular fat in *longissimus dorsi* muscle of growing lambs

                                                                                    Diets[1](#tfn1-ajas-25-5-648-8){ref-type="table-fn"}   SEM        Effect                                                                                                                                      
  --------------------------------------------------------------------------------- ------------------------------------------------------ ---------- ---------- ---------- ------- ------------------------------------------------------ ------------------------------------------------------ --------------------------------------------------
  Intramuscular fat (g/100 g fresh muscle)                                          3.92 ^b^                                               5.00 ^b^   7.34 ^a^   6.39 ^a^   0.420   ns                                                     [\*\*](#tfn7-ajas-25-5-648-8){ref-type="table-fn"}     [\*](#tfn6-ajas-25-5-648-8){ref-type="table-fn"}
  Fatty acid composition (g/100 g total fatty acids)                                                                                                                                                                                                                                              
   Myristic acid (14:0)                                                             3.64^a^                                                3.52^bc^   3.57^ab^   3.45^c^    0.029   [\*\*](#tfn7-ajas-25-5-648-8){ref-type="table-fn"}     [\*](#tfn6-ajas-25-5-648-8){ref-type="table-fn"}       ns
   Palmitic acid (16:0)                                                             24.3                                                   24.2       24.2       24.1       0.040   ns                                                     ns                                                     ns
   Palmitoleic acid (16:1)                                                          2.23^b^                                                2.32^a^    2.24^b^    2.26^ab^   0.027   ns                                                     ns                                                     ns
   Stearic acid (18:0)                                                              16.7                                                   16.6       16.6       16.7       0.04    ns                                                     ns                                                     ns
   Oleic acid (18:1)                                                                36.2^b^                                                36.3^ab^   36.3^ab^   36.4^a^    0.06    ns                                                     ns                                                     ns
   Vaccenic acid (18:1, *trans-11*)                                                 1.58^c^                                                1.70^ab^   1.65^b^    1.74^a^    0.019   [\*\*\*](#tfn8-ajas-25-5-648-8){ref-type="table-fn"}   [\*](#tfn6-ajas-25-5-648-8){ref-type="table-fn"}       ns
   Linoleic (18:2)                                                                  3.22                                                   3.29       3.26       3.24       0.03    ns                                                     ns                                                     ns
   Linolenic (18:3)                                                                 0.55^ab^                                               0.55^ab^   0.58^a^    0.51^b^    0.017   ns                                                     ns                                                     ns
   CLA[2](#tfn2-ajas-25-5-648-8){ref-type="table-fn"} (18:2, *cis*-9, *trans*-11)   0.54^b^                                                0.53^b^    0.61^a^    0.55^b^    0.009   [\*\*](#tfn7-ajas-25-5-648-8){ref-type="table-fn"}     [\*\*](#tfn7-ajas-25-5-648-8){ref-type="table-fn"}     [\*](#tfn6-ajas-25-5-648-8){ref-type="table-fn"}
   CLA (18:2, *trans*-10, *cis*-12)                                                 0.18^ab^                                               0.17^b^    0.18^ab^   0.19^a^    0.005   ns                                                     [\*](#tfn6-ajas-25-5-648-8){ref-type="table-fn"}       [\*](#tfn6-ajas-25-5-648-8){ref-type="table-fn"}
   Arachidonic acid (20:4)                                                          0.71                                                   0.74       0.74       0.75       0.01    ns                                                     ns                                                     ns
   Eicosapentaenoic acid (20:5)                                                     3.12                                                   3.11       3.14       3.11       0.015   ns                                                     ns                                                     ns
   Docosapentaenoic acid (22:5)                                                     0.96^bc^                                               0.93^c^    1.00^ab^   1.03^a^    0.02    ns                                                     [\*\*](#tfn7-ajas-25-5-648-8){ref-type="table-fn"}     ns
   Docosahexaenoic acid (22:6)                                                      0.99                                                   1.02       1.01       1.04       0.016   ns                                                     ns                                                     ns
   Others                                                                           5.20^a^                                                5.03^ab^   5.02^ab^   4.96^b^    0.053   [\*](#tfn6-ajas-25-5-648-8){ref-type="table-fn"}       [\*](#tfn6-ajas-25-5-648-8){ref-type="table-fn"}       ns
  CLA                                                                               0.73^b^                                                0.69^c^    0.78^a^    0.74^b^    0.010   [\*\*](#tfn7-ajas-25-5-648-8){ref-type="table-fn"}     [\*\*\*](#tfn8-ajas-25-5-648-8){ref-type="table-fn"}   ns
  SFA[3](#tfn3-ajas-25-5-648-8){ref-type="table-fn"}                                44.5^a^                                                44.3^b^    44.3^b^    44.3^b^    0.05    [\*](#tfn6-ajas-25-5-648-8){ref-type="table-fn"}       [\*](#tfn6-ajas-25-5-648-8){ref-type="table-fn"}       ns
  MUFA[4](#tfn4-ajas-25-5-648-8){ref-type="table-fn"}                               40.0^b^                                                40.3^a^    40.1^b^    40.3^a^    0.055   [\*\*\*](#tfn8-ajas-25-5-648-8){ref-type="table-fn"}   ns                                                     ns
  PUFA[5](#tfn5-ajas-25-5-648-8){ref-type="table-fn"}                               10.3^b^                                                10.3^b^    10.5^a^    10.4^ab^   0.05    ns                                                     [\*\*](#tfn7-ajas-25-5-648-8){ref-type="table-fn"}     ns
  *cis*-9, *trans*-11 CLA/vaccenic acid                                             0.34^b^                                                0.31^c^    0.37^a^    0.31^c^    0.007   [\*\*\*](#tfn8-ajas-25-5-648-8){ref-type="table-fn"}   [\*](#tfn6-ajas-25-5-648-8){ref-type="table-fn"}       ns

Diets: NTNS = No tea saponins or soybean oil; TS = Tea saponins; SO = Soybean oil; TS-SO = Tea saponins plus soybean oil.

CLA = Conjugated linoleic acid.

SFA = Saturated fatty acid (sum of C14:0, C16:0 and C18:0).

MUFA = Monounsaturated fatty acid (sum of C16:1, C18:1 and *trans*-11 C18:1).

PUFA = Polyunsaturated fatty acid (sum of C18:2, C18:3, *cis*-9, *trans*-11 C18:2, *trans*-10, *cis*-12 C18:2, C20:4, C20:5, C22:5 and C22:6).

p\<0.05;

p\<0.01;

p\<0.001;

ns = Not significant.
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